Peter Nicklin has been named corporate vice president of Baxter World Trade Corp. and president of Baxter Europe, effective October 1, 2006. Mr. Nicklin will be responsible for the company's European operations, which had revenues totaling more than $3 billion in 2005. He will be based in Zurich, Switzerland, reporting to John J. Greisch, corporate vice president and president of Baxter's international operations.
"With his significant international experience and outstanding track record within the pharmaceutical and medical device industries, Peter is ideally suited to lead our European organization," said Mr. Greisch. "His talents in developing businesses and people will help drive continued growth for Baxter across Europe."
Mr. Nicklin joins the company from Bayer AG where he served as president of the Animal Health Division, board member of Bayer HealthCare AG and regional head of Bayer HealthCare's business in Asia Pacific. Prior to joining Bayer, he was responsible for the Western and Central European pharmaceutical businesses of Novartis AG. He also held several general and executive management positions for Bristol-Myers Squibb Co. in Europe and Asia.